… as intravenous heparin or oral warfarin.A stroke was defined as a clinical event with acute
onset … of atrial fibrillation. Follow-up of patients was obtained within at least a 3-month interval. …

… for evidence-based medicine approach to the use of online … atrial fibrillation patients with
mild to severe renal impairment, new oral anticoagulants are more effective in prevent stroke …

… risk of cardioembolic stroke before novel oral anticoagulants (NOACs) … atrial fibrillation in
the four studies included RE-LY trial, ROCKET AF trial, ENGAGE AF trial, and ARISTOTLE trial…

… oral anticoagulants rivaroxaban and dabigatran to antiplatelet therapy for secondary stroke
prevention, the New Approach … and atrial fibrillation: benefit and risks of old and new oral …

… and vessel studies, telemetry monitoring for atrial fibrillation (AF), … stroke workup algorithms
would be simplified and direct oral … with this approach, along with further studies underway to …

… 非瓣膜性心房颤动(nonvalvular atrial fibrillation, NVAF)是AF中… In view of the challenges of
OAC selec-tion in patients with … oral anticoagulants, NOACs),也称新型口服抗凝药(novel oral …

… New York City 10032 The Warfarin-Aspirin Recurrent Stroke Study : For stroke patients with
no atrial fibrillation or … the success of warfarin with atrial fib rillation would show comparable …

… Abstract: Atrial fibrillation is a common arrhythmia, the new oral anticoagulants (NOACs) …
of patients with atrial fibrillation, the use of rivaroxaban is more common, but clinical use of …

… standard research approach for the new drug approval, such a trial may fail … atrial fibrillation
at NCSS. We efficiently identified 2,357 non-valvular AF patients with newly prescribed oral …

… ) and a CHA 2 DS 2 -VASc clinical risk score of 2 or above, were chosen for this study. Patients
were randomized into two groups and orally treated with a combination of aspirin (100 mg…